Soluble β-amyloid induces Alzheimer's disease features in human fibroblasts and in neuronal tissues

Life Sciences

Volumn 59, Issue 5-6, 1996, Pages 491-498

  Etcheberrigaray, René ^a   Payne, Jennifer L ^b   Alkon, Daniel L ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

amyloid; Alzheimer's disease; K+ channles

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; POTASSIUM CHANNEL; PROTEIN KINASE C;

ALZHEIMER DISEASE; CONFERENCE PAPER; FIBROBLAST; HUMAN; MEMORY CONSOLIDATION; NERVE CELL; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE;

EID: 0030567763     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00328-1     Document Type: Conference Paper

References (41)

1. 1. R.N. KATZMAN, Engl. J. Med. 314 964-973 (1986).
2. 2. L. BERG and J.C. MORRIS, Alzheimer Disease, R.D. TERRY, R. KATZMAN and K.L. BICK (eds), 9-25, Raven Press, New York (1994).
3. 3. W.B. BONDI, D.P. SALOMON and N. BUTTERS, Alzheimer Disease, R.D. TERRY, R. KATZMAN and K.L. BICK (eds), 41-63, Raven Press, New York (1994).
4. 4. D.L. ALKON, Memory Traces in the Brain, Cambridge Univ. Press, New York (1987).
5. 5. D.L. ALKON, Sci. Ameri. 260 42-50 (1989).
6. 6. R. ETCHEBERRIGARAY, D.L. MATZEL, I.I. LEDERHENDLER and D.L. ALKON, Proc. Natl. Acad. Sci. USA 89 7184-7188 (1992).
7. 7. J.V. SANCHEZ-ANDRES and D.L. ALKON, J. Neurophysiol. 65 796-807 (1991).
8. 8. T.J. NELSON, T. YOSHIOKA, S. TOYOSHIMA, Y-F. HAN and D.L. ALKON, Proc. Natl. Acad. Sci. USA 91 9287-9291 (1994).
9. 9. J.E. SEEGMILLER, F. M. ROSENBLOOM and N. W. KELLEY, Science 155 1682-1686 (1967).
10. 10. S. OKADA and J.S. O'BRIEN, Science 165 698-701 (1969).
11. 11. A.C. BAKER, L-W. KO and J.P. BLASS, Age 11 60-65 (1988).
12. 12. R.B. SCOTT, JAGS 41 268-276 (1993).
13. 13. H. HSUEH-MEEI, R. MARTINS, S. GANDY, R. ETCHEBERRIGARAY, E. ITO, D.L. ALKON, J. BLASS and G. GIBSON, Proc. N. Y. Acad. Sci. 747 225-244 (1994).
14. 15. R. ETCHEBERRIGARAY , E. ITO, K. OKA, B. TOFEL-GREHL, G.E. GIBSON and D.L. ALKON Proc. Natl. Acad. Sci. USA 90 8209-8213 (1993).
15. 16. C. PETERSON, R.R. RATAN, M.L. SHELANSKI and J.E. GOLDMAN, Proc. Natl. Acad. Sci. USA 83 7999-8001 (1986).
16. 17. G.E. GIBSON, P. NIELSON, K.A. SHERMAN and J.P. BLASS, Biol. Psychiatry 22, 1079-1086 (1987).
17. 18. C. PETERSON, R.R. RATAN, M.L. SHELANSKI and J.E. GOLDMAN, Neurobiol. Aging 9 261-266 (1988).
18. 19. L.A. BORDEN, F.R. MAXFIELD, J.E. GOLDMAN and M.L. SHELANSKI, Neurobiol. Aging 13 33-38 (1992).
19. 20. K.R. MCCOY, R.D. MULLINS, T.G. NEWCOMB, G.M. NG, G. PAVLINKOVA, R.J. POLINSKY, L.E. NEE and J.E. SISKEN, Neurobiol. Aging 14 447-455 (1993).
20. 21. K.H. LE QUANG SANG, E. MIGNOT, J.C. GILBERT, R. HUGUET, J.P. AQUINO, O. REGNIER, and M.A. DEVYNCK, Biol. Psychiatry 3 391-393 (1993).
21. 22. M. SAKAKIBARA, D.L. ALKON, J.T. NEARY, E. HELDMAN and R. GOULD, Biophys. J. 50 797-803 (1986).
22. 23. E. ITO, K. OKA, R. ETCHEBERRIGARAY, T.J. NELSON, D.L. MCPHIE, B. TOFEL-GREHL, G.E. GIBSON, and D.L. ALKON, Proc. Natl. Acad. Sci. USA 91 534-538 (1994).
23. 24. N. HIRASHIMA, R. ETCHEBERRIGARAY, S. BERGAMASCHI, M. RACCHI, F. BATTAINI, G. BINETTI, S. GOVONI, and D.L. ALKON, Neurobiol. Aging (in press).
24. 25. H-M. HUANG, T-A. LIN, G.Y. SUN and G.E. GIBSON, J. Neurochem. 64 761-766 (1995).
25. 26. KIM CS, Y-F. HAN, R. ETCHEBERRIGARAY, T.J. NELSON, J.L. OLDS, T. YOSHIOKA, and D.L. ALKON, Proc. Natl. Acad. Sci. USA 92 3060-3064 (1995).
26. 27. L.E. NEE, R.J. POLINSKI, E. ROSWELL, H. WEINGARTNER, S. SMALLBERG and M. EBERT, Arch. Neurol 40 203-208 (1983).
27. 28. National Institute of Aging, 1991 Catalog of Cell Lines (1991).
28. 29. T.D. BIRD, Alzheimer Disease, R.D. TERRY, R. KATZMAN and K.L. BICK (eds), 65-74, Raven Press, New York (1994).
29. 30. D.J. SELKOE, Neuron 6 487-498 (1991).
30. 31. A.I. BUSH, K. BEYREUTHER and C.L. MASTERS, Pharmac. Ther. 56 97-117 (1992).
31. 32. M.P. MATTSON, B. CHENG, D. DAVIS, K. BRYANT, I. LIEBERBURG and R.E. RYDEL, J. Neurosci. 12 376-389 (1992).
32. 33. B. REGLAND and C-G. GOTTFRIES, Lancet 340 467-469 (1992).
33. 34. D.J. SELKOE, Annu. Rev. Neurosci. 17 489-517 (1994).
34. 35. C.W. COTMAN and C.J. PIKE, Alzheimer Disease, R.D. TERRY, R. KATZMAN and K.L. BICK (eds), 305-315, Raven Press, New York (1994).
35. 36. N. ARISPE, H.B. POLLARD and E. ROJAS, Proc. Natl. Acad. Sci. USA 90 10573-10577 (1993).
36. 37. R. ETCHEBERRIGARAY, E. ITO, C.S. KIM and D.L. ALKON, Science 264 276-279 (1994).
37. 38. SIMMONS, M.A. and SCHNEIDER, C.R., Neuroscience Letters 150 133-136 (1993).
38. 39. GALDZICKI, Z., FURUYAMA, R., WALDHWANI, K.C. EHRENSTEIN, G. and RAPOPORT, S.I., Soc. Neurosci. Abs. 19 397a (1993).
39. 40. GALDZICKI, Z., FURUYAMA, R., WALDHWANI, K.C., RAPOPORT, S.I., and EHRENSTEIN, G., Brain Research, 646 332-336 (1994).
40. 41. GOOD, T.A., SMITH, D.O., and MURPHY, R.M., Biophys. J. 70 296-304 (1996).
41. 42. FURUKAWA, K., BARGER, S.W., BLALOCK, E.M., and MATTSON, M.P., Nature, 379 74-78 (1996).